Integrin α6β4 signals through DNA damage response pathway to sensitize breast cancer cells to cisplatin
Article in Frontiers in Oncology (November 2022)
The most recent citing publications are shown below. View all 18 publications that cite this research output on Dimensions.
Alterations in the p53 isoform ratio govern breast cancer cell fate in response to DNA damage
Article in Cell Death & Disease (October 2022)
Differences in genetics and microenvironment of lung adenocarcinoma patients with or without TP53 mutation
Article in BMC Pulmonary Medicine (October 2021)